Cellular Biomedicine Group, Inc. logo

CBMG

Cellular Biomedicine Group, Inc. · NASDAQ

Cellular Biomedicine Group, Inc. (CBMG) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for CBMG in the last 30 days. The most recent was published Mar 3, 2021.

Latest news

25 items

CBMG FAQ

6 questions
  • What is the latest news on CBMG?
    Quantisnow has not tracked any new filings, ratings or press releases for CBMG in the last 30 days. The most recent wire item was published on March 3, 2021.
  • Where does CBMG stock trade?
    Cellular Biomedicine Group, Inc. (CBMG) is listed on NASDAQ.
  • What sector and industry is CBMG in?
    Cellular Biomedicine Group, Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • When did Cellular Biomedicine Group, Inc. go public?
    Cellular Biomedicine Group, Inc. (CBMG) completed its IPO in n/a.
  • What companies are similar to CBMG?
    Notable peers in the same industry include BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.), RVMD (Revolution Medicines Inc.), AMGN (Amgen Inc.). Compare CBMG side-by-side with any of them on Quantisnow.
  • How can I track CBMG on Quantisnow?
    Quantisnow aggregates Cellular Biomedicine Group, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CBMG to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change